Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Botulinum Toxin Therapy in Hidradenitis Suppurativa

View source ↗

Summary

This clinical trial update reports that a study evaluating botulinum toxin therapy for hidradenitis suppurativa is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin therapy (botulinum toxin)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Hidradenitis Suppurativa, Hyperhidrosis | Status: RECRUITING